美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kalaris Therapeutics Inc.

6.99

+0.29004.33%

盘后：6.990.00000.00%16:05 EDT

成交量：1.92万

成交额：13.50万

市值：1.31亿

市盈率：-0.67

高：7.31

开：6.52

低：6.52

收：6.70

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Kalaris Therapeutics Inc.

交易所：

NASDAQ

成立时间：

2019

员工人数：

14

公司地址：

628 Middlefield Road,Palo Alto,California,United States

官网：

http://www.allovir.com

邮编：

94301

电话：

- -

传真：

- -

简介：

Kalaris Therapeutics, Inc.成立于2013年8月16日，是特拉华州的一家有限责任公司。该公司是一家领先的临床晚期细胞治疗公司，开发高度创新的异基因T细胞疗法来治疗和预防毁灭性的病毒性疾病。该公司的创新和专有的病毒特异性T细胞（VST）治疗平台能够产生现成的VST，旨在恢复T细胞缺陷患者的免疫力。

董事

名称

职位

David Hallal

Chief Executive Officer and Director

Vikas Sinha

President, Chief Financial Officer and Director

Ansbert Gadicke

Director

Diana Brainard

Director

Jeffrey S. Bornstein

Director

John Wilson

Director

Juan Vera

Director

Malcolm Brenner

Director

Morana Jovan Embiricos

Director

股东

名称

职位

David Hallal

Chief Executive Officer and Director

Vikas Sinha

President, Chief Financial Officer and Director

Agustin Melian

Chief Medical Officer

Ann Leen

Chief Scientific Officer

Brett Hagen

Chief Accounting Officer

Edward Miller

General Counsel

Ercem Atillasoy

Chief Regulatory and Safety Officer

Jeroen van Beek

Chief Commercial Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/KLRS/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KLRS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRS\",,,,,undefined,":{"symbol":"KLRS","market":"US","secType":"STK","nameCN":"Kalaris Therapeutics Inc.","latestPrice":6.99,"timestamp":1744920000000,"preClose":6.7,"halted":0,"volume":19203,"hourTrading":{"tag":"盘后","latestPrice":6.99,"preClose":6.99,"latestTime":"16:05 EDT","volume":23,"amount":160.77,"timestamp":1744920312165},"delay":0,"floatShares":5446509,"shares":18702413,"eps":-10.437743,"marketStatus":"休市中","change":0.29,"latestTime":"04-17 16:00:00 EDT","open":6.52,"high":7.31,"low":6.52,"amount":135039.7002,"amplitude":0.11791,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.437743,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1596081600000,"exchange":"NASDAQ","adjPreClose":6.7,"postHourTrading":{"tag":"盘后","latestPrice":6.99,"preClose":6.99,"latestTime":"16:05 EDT","volume":23,"amount":160.77,"timestamp":1744920312165},"volumeRatio":0.1452943340841707},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRS\",,,,,undefined,":{"symbol":"KLRS","floatShares":5446509,"roa":"-681.04%","roe":"--","lyrEps":-10.437743,"volumeRatio":0.1452943340841707,"shares":18702413,"dividePrice":0,"high":7.31,"amplitude":0.11791,"preClose":6.7,"low":6.52,"week52Low":5.865,"pbRate":"-1.35","week52High":24.15,"institutionHeld":0,"latestPrice":6.99,"eps":-10.437743,"divideRate":0,"volume":19203,"delay":0,"ttmEps":-10.437743,"open":6.52,"prevYearClose":9.66,"prevWeekClose":7.23,"prevMonthClose":8.03,"prevQuarterClose":8.03,"fiveDayClose":7.31,"twentyDayClose":11.4,"sixtyDayClose":9.2},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1900954228,"yearFounded":2019,"employeeNum":14,"address":"628 Middlefield Road,Palo Alto,California,United States","zipCode":"94301"},"stockCompanyDetail":{"websiteUrl":"http://www.allovir.com","stockEarnings":[{"period":"1week","weight":-0.0438},{"period":"1month","weight":-0.2875},{"period":"3month","weight":-0.2468},{"period":"6month","weight":-0.6069},{"period":"1year","weight":-0.5985},{"period":"ytd","weight":-0.2764}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kalaris Therapeutics, Inc.成立于2013年8月16日，是特拉华州的一家有限责任公司。该公司是一家领先的临床晚期细胞治疗公司，开发高度创新的异基因T细胞疗法来治疗和预防毁灭性的病毒性疾病。该公司的创新和专有的病毒特异性T细胞（VST）治疗平台能够产生现成的VST，旨在恢复T细胞缺陷患者的免疫力。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.05141},{"month":2,"riseRate":0.8,"avgChangeRate":0.066777},{"month":3,"riseRate":0.2,"avgChangeRate":-0.236404},{"month":4,"riseRate":0.4,"avgChangeRate":-0.104038},{"month":5,"riseRate":0.25,"avgChangeRate":-0.027821},{"month":6,"riseRate":0.25,"avgChangeRate":-0.072525},{"month":7,"riseRate":0.5,"avgChangeRate":0.034661},{"month":8,"riseRate":0.8,"avgChangeRate":0.189154},{"month":9,"riseRate":0.6,"avgChangeRate":-0.014837},{"month":10,"riseRate":0.2,"avgChangeRate":-0.070906},{"month":11,"riseRate":0.6,"avgChangeRate":0.030408},{"month":12,"riseRate":0,"avgChangeRate":-0.295433}],"exchange":"NASDAQ","name":"Kalaris Therapeutics Inc.","nameEN":"Kalaris Therapeutics Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KLRS\",market:\"US\",,,undefined,":{"directors":[{"name":"David Hallal","position":"Chief Executive Officer and Director"},{"name":"Vikas Sinha","position":"President, Chief Financial Officer and Director"},{"name":"Ansbert Gadicke","position":"Director"},{"name":"Diana Brainard","position":"Director"},{"name":"Jeffrey S. Bornstein","position":"Director"},{"name":"John Wilson","position":"Director"},{"name":"Juan Vera","position":"Director"},{"name":"Malcolm Brenner","position":"Director"},{"name":"Morana Jovan Embiricos","position":"Director"}],"executives":[{"name":"David Hallal","position":"Chief Executive Officer and Director"},{"name":"Vikas Sinha","position":"President, Chief Financial Officer and Director"},{"name":"Agustin Melian","position":"Chief Medical Officer"},{"name":"Ann Leen","position":"Chief Scientific Officer"},{"name":"Brett Hagen","position":"Chief Accounting Officer"},{"name":"Edward Miller","position":"General Counsel"},{"name":"Ercem Atillasoy","position":"Chief Regulatory and Safety Officer"},{"name":"Jeroen van Beek","position":"Chief Commercial Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KLRS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-07","symbol":"KLRS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1741323600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-01-16","symbol":"KLRS","defaultRemindTime":1737037800000,"type":"split","dateTimestamp":1737003600000,"forFactor":23,"toFactor":1,"ratio":23},{"market":"US","date":"2024-11-12","symbol":"KLRS","fiscalQuarterEnding":"2024/09","expectedEps":-0.14,"name":null,"time":"盘后","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.04},{"market":"US","date":"2024-08-09","symbol":"KLRS","fiscalQuarterEnding":"2024/06","expectedEps":-0.1,"name":null,"time":"盘前","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2024-05-13","symbol":"KLRS","fiscalQuarterEnding":"2024/03","expectedEps":-0.16,"name":null,"time":"盘后","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KLRS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KLRS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KLRS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KLRS","date":"2025-04-17","current":-1.811647,"percent":0.882353,"low":-2.839148,"twenty":-2.361089,"median":-2.042834,"eighty":-1.880868,"high":-1.746752,"avg":-2.113287,"sd":0.282591,"marketCap":125306167},"quantilePoints":[{"date":"2025-03-28","current":-2.436259,"twenty":-2.629862,"median":-2.463299,"eighty":-2.415709,"marketCap":168508741},{"date":"2025-04-04","current":-2.000923,"twenty":-2.457891,"median":-2.325397,"eighty":-2.168027,"marketCap":138397856},{"date":"2025-04-11","current":-1.976588,"twenty":-2.405434,"median":-2.167216,"eighty":-1.951712,"marketCap":136714639},{"date":"2025-04-17","current":-1.811647,"twenty":-2.361089,"median":-2.042834,"eighty":-1.880868,"marketCap":125306167}],"updateTime":1745134398712}}}